SEC Form 4 · accession 0001104659-19-011180
Osmotica Pharmaceuticals plc · OSMT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Brian A Markison
Officer — Chief Executive Officer · Director
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 5:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001739426
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Feb 25, 2019 | A | 387,991 | $0.00 | A | 1,876,233 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents a grant of restricted stock units.